|
95
|
258
|
2uzbB |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
80
|
296
|
2uzbA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
84
|
296
|
2uzlA |
Crystal structure of human cdk2 complexed with a thiazolidinone inhibitor |
|
81
|
296
|
2uueA |
Replace: a strategy for iterative design of cyclin binding groove inhibitors |
|
93
|
258
|
2uueB |
Replace: a strategy for iterative design of cyclin binding groove inhibitors |
|
75
|
298
|
2r3jA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
81
|
298
|
2r3mA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
79
|
298
|
2r3lA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
86
|
298
|
2r3pA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
83
|
298
|
2r3nA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
87
|
298
|
2r3hA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
86
|
298
|
2r3qA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
84
|
298
|
2r3rA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
84
|
298
|
2r3fA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
81
|
298
|
2r3gA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
79
|
298
|
2r3kA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
79
|
298
|
2r64A |
Crystal structure of a 3-aminoindazole compound with cdk2 |
|
83
|
298
|
2r3iA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
83
|
298
|
2r3oA |
Crystal structure of cyclin-dependent kinase 2 with inhibitor |
|
74
|
289
|
2jgzA |
Crystal structure of phospho-cdk2 in complex with cyclin b |
|
97
|
260
|
2jgzB |
Crystal structure of phospho-cdk2 in complex with cyclin b |
|
95
|
257
|
2iw8B |
Structure of human thr160-phospho cdk2-cyclin a f82h-l83v-h84d mutant with an o6-cyclohexylmethylguanine inhibitor |
|
77
|
298
|
2j9mA |
Crystal structure of cdk2 in complex with macrocyclic aminopyrimidine |
|
81
|
296
|
2iw6A |
Structure of human thr160-phospho cdk2-cyclin a complexed with a bisanilinopyrimidine inhibitor |
|
95
|
257
|
2iw9B |
Structure of human thr160-phospho cdk2-cyclin a complexed with a bisanilinopyrimidine inhibitor |
|
94
|
257
|
2iw6B |
Structure of human thr160-phospho cdk2-cyclin a complexed with a bisanilinopyrimidine inhibitor |
|
80
|
297
|
2i40A |
Cdk2/cyclin a complexed with a thiophene carboxamide inhibitor |
|
95
|
257
|
2i40B |
Cdk2/cyclin a complexed with a thiophene carboxamide inhibitor |
|
85
|
299
|
2g9xA |
Structure of thr 160 phosphorylated cdk2/cyclin a in complex with the inhibitor nu6271 |
|
97
|
262
|
2g9xB |
Structure of thr 160 phosphorylated cdk2/cyclin a in complex with the inhibitor nu6271 |
|
82
|
298
|
2fvdA |
Cyclin dependent kinase 2 (cdk2) with diaminopyrimidine inhibitor |
|
81
|
298
|
2exmA |
Human cdk2 in complex with isopentenyladenine |
|
74
|
298
|
2ds1A |
Human cyclin dependent kinase 2 complexed with the cdk4 inhibitor |
|
68
|
298
|
2duvA |
Structure of cdk2 with a 3-hydroxychromones |
|
86
|
297
|
2cchA |
The crystal structure of cdk2 cyclin a in complex with a substrate peptide derived from cdc modified with a gamma-linked atp analogue |
|
80
|
292
|
2cjmA |
Mechanism of cdk inhibition by active site phosphorylation: cdk2 y15p t160p in complex with cyclin a structure |
|
101
|
260
|
2cchB |
The crystal structure of cdk2 cyclin a in complex with a substrate peptide derived from cdc modified with a gamma-linked atp analogue |
|
78
|
296
|
2c5xA |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
|
80
|
296
|
2c5vA |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
|
80
|
297
|
2c5yA |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
|
85
|
296
|
2c5oA |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
|
81
|
298
|
2c69A |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
97
|
258
|
2c6tB |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
81
|
298
|
2c6iA |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
86
|
296
|
2c6tA |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
94
|
258
|
2c5oB |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
|
79
|
296
|
2c68A |
Crystal structure of the human cdk2 complexed with the triazolopyrimidine inhibitor |
|
97
|
258
|
2c4gB |
Structure of cdk2-cyclin a with pha-533514 |
|
89
|
301
|
2c4gA |
Structure of cdk2-cyclin a with pha-533514 |
|
96
|
258
|
2c5nB |
Differential binding of inhibitors to active and inactive cdk2 provides insights for drug design |
